(Total Views: 548)
Posted On: 03/14/2021 7:42:59 PM
Post# of 153886
Re: nothingspecial #82984
“So are you suggesting that this is not an extension of cd12 & more of a stand alone trial?”
Good questions. I was under the assumption that the 140 patient protocol is a standalone trial, hence the “CD16” identifier. I don’t think an extension of CD12 would get its own identifier, but I could be wrong.
Good questions. I was under the assumption that the 140 patient protocol is a standalone trial, hence the “CD16” identifier. I don’t think an extension of CD12 would get its own identifier, but I could be wrong.
(1)
(0)
